Answers are grounded in this paper and cite their sources.
We characterized bacteriophage Abs1 that infects clinical Acinetobacter baumannii isolates via the highly prevalent and conserved outer-membrane protein receptor, OprC. However, phage Abs1 is unable to infect capsulated A. baumannii strains as the capsule prevents phage access to its underlying receptor. To circumvent this, we combined phage Abs1 with recombinant depolymerases targeting the major A. baumannii capsule types. In a murine bacteremia model, this combination significantly reduced bacterial burden caused by diverse, capsulated A. baumannii strains.
No takes yet. Share an insight, caveat, or question.
Kan et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: